Liminatus Pharma, Inc. (LIMN, LIMNW)

CIK 1971387 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Liminatus Pharma, Inc..

Recent SEC filings

FiledFormAccession number
Aug 18, 20268-K0001104659-26-098335
Aug 14, 202610-Q0001104659-26-097304
Aug 4, 20268-K0001104659-26-090423
Jul 30, 20268-K0001104659-26-088380
Jul 24, 20268-K0001104659-26-086674
Jul 22, 2026SCHEDULE 13G0001104659-26-085882
Jul 14, 202640001104659-26-083588
Jul 14, 2026SCHEDULE 13D/A0001104659-26-083585
Jul 13, 2026DEF 14A0001104659-26-082905
Jul 6, 2026SCHEDULE 13G/A0001104659-26-080802
Jul 6, 202640001104659-26-080806
Jul 6, 202630001104659-26-080804
Jul 6, 20268-K0001104659-26-080613
Jun 30, 2026PRE 14A0001104659-26-078994
Jun 24, 2026S-10001104659-26-076958
Jun 18, 2026D0001104659-26-075732
Jun 3, 2026424B30001104659-26-069843
Jun 3, 20268-K0001104659-26-070173
May 27, 20268-K0001104659-26-066974
May 20, 20268-K0001104659-26-064585
May 15, 202610-Q0001104659-26-062734
Mar 31, 202610-K0001104659-26-037933
Mar 4, 20268-K0001104659-26-023467
Feb 20, 2026SCHEDULE 13G0001213900-26-018820
Feb 18, 2026424B40001104659-26-016706